Fernando Dip

Fernando Dip

Auto-generated profile, based on publicly available information

Fernando Dip

From the Department of General Surgery, University of Buenos Aires, Buenos Aires, Argentina (F Dip, R Aleman, HR Dip, Rancati, Eiben, Marinelli, Ghiselli, Sinagra, Rosenthal)

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
FDFernando Dip
Fernando Dip
JFJorge Falco
Jorge Falco
SVSilvina Verna
Silvina Verna
MPMarcos Prunello
Marcos Prunello
MLMatias Loccisano
Matias Loccisano
RRRaul Rosenthal
Raul Rosenthal
Parathyroid glands are difficult to identify during total thyroidectomies, and accidental resection can lead to problematic postoperative hypocalcemia. Our main goals were to evaluate the effectiveness of using near-infrared light (NIRL) autofluorescence intraoperatively for parathyroid gland identification and to measure its impact on postoperative hypocalcemia incidence. Total thyroidectomies were performed on 170 patients with different thyroid pathologies, block-randomized (1:1) into 2 equal groups. Among controls, traditional overhead white light (WL) was used throughout. In the experimental group, NIRL was used to enhance parathyroid gland recognition before thyroid dissection. The number of parathyroid glands identified was compared after thyroid dissection in controls using WL vs pre-dissection in the experimental using NIRL and with WL vs NIRL before thyroid dissection in the experimental group. Postoperative serum calcium levels and hypocalcemia rates were compared. The mean number of parathyroid glands identified pre-dissection with NIRL was the same identified post-dissection with WL (3.5 vs 3.6). In the experimental group, converting from WL to NIRL increased the number of glands detected from 2.6 to 3.5 (p < 0.001), and revealed at least 1 previously missed gland in 67.1% of patients. Calcium levels ≤7.5 mg/dL were one-tenth as common in the NIRL group (p = 0.005). The adjusted odds of hypocalcemia developing increased by 15% for every 5-g increase in thyroid gland weight (odds ratio 1.15; 95% CI 1.06 to 1.25). All hypocalcemia resolved within 6 months. Using NIRL during thyroidectomy increases intraoperative identification of parathyroid glands, enhances their detection before thyroid dissection, and decreases the incidence of postoperative hypocalcemia.

11 January 2014 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
FDFernando D. Dip
Fernando D. Dip
DADomenech Asbun
Domenech Asbun
ARArmando Rosales-Velderrain
Armando Rosales-Velderrain
EMEmanuele Lo Menzo
Emanuele Lo Menzo
CSConrad H. Simpfendorfer
Conrad H. Simpfendorfer
RRRaul J. Rosenthal
Raul J. Rosenthal

22 November 2022 in Surgery
Verified
Journal Article
Open access
SWSteven D. Wexner
Steven D. Wexner
MAMahmoud Abu-Gazala
Mahmoud Abu-Gazala
LBLuigi Boni
Luigi Boni
KBKenneth Buxey
Kenneth Buxey
RCRonan Cahill
Ronan Cahill
RRRaul J. Rosenthal
Raul J. Rosenthal
Fluorescence imaging with indocyanine green is increasingly being used in colorectal surgery to assess anastomotic perfusion, and to detect sentinel lymph nodes. In this 2-round, online, Delphi survey, 35 international experts were asked to vote on 69 statements pertaining to patient preparation and contraindications to fluorescence imaging during colorectal surgery, indications, technical aspects, potential advantages/disadvantages, and effectiveness versus limitations, and training and research. Methodological steps were adopted during survey design to minimize risk of bias. More than 70% consensus was reached on 60 of 69 statements, including moderate-strong consensus regarding fluorescence imaging's value assessing anastomotic perfusion and leak risk, but not on its value mapping sentinel nodes. Similarly, although consensus was reached regarding most technical aspects of its use assessing anastomoses, little consensus was achieved for lymph-node assessments. Evaluating anastomoses, experts agreed that the optimum total indocyanine green dose and timing are 5 to 10 mg and 30 to 60 seconds pre-evaluation, indocyanine green should be dosed milligram/kilogram, lines should be flushed with saline, and indocyanine green can be readministered if bright perfusion is not achieved, although how long surgeons should wait remains unknown. The only consensus achieved for lymph-node assessments was that 2 to 4 injection points are needed. Ninety-six percent and 100% consensus were reached that fluorescence imaging will increase in practice and research over the next decade, respectively. Although further research remains necessary, fluorescence imaging appears to have value assessing anastomotic perfusion, but its value for lymph-node mapping remains questionable.

20 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
LMLysanne de Muynck
Lysanne de Muynck
KWKevin P. White
Kevin P. White
AAAdnan Alseidi
Adnan Alseidi
EBELISA BANNONE
ELISA BANNONE
LBLuigi Boni
Luigi Boni
JMJ. Sven D. Mieog
J. Sven D. Mieog
Indocyanine green (ICG) is one of the only clinically approved near-infrared (NIR) fluorophores used during fluorescence-guided surgery (FGS), but it lacks tumor specificity for pancreatic ductal adenocarcinoma (PDAC). Several tumor-targeted fluorescent probes have been evaluated in PDAC patients, yet no uniformity or consensus exists among the surgical community on the current and future needs of FGS during PDAC surgery. In this first-published consensus report on FGS for PDAC, expert opinions were gathered on current use and future recommendations from surgeons’ perspectives. A Delphi survey was conducted among international FGS experts via Google Forms. Experts were asked to anonymously vote on 76 statements, with ≥70% agreement considered consensus and ≥80% participation/statement considered vote robustness. Consensus was reached for 61/76 statements. All statements were considered robust. All experts agreed that FGS is safe with few drawbacks during PDAC surgery, but that it should not yet be implemented routinely for tumor identification due to a lack of PDAC-specific NIR tracers and insufficient evidence proving FGS’s benefit over standard methods. However, aside from tumor imaging, surgeons suggest they would benefit from visualizing vasculature and surrounding anatomy with ICG during PDAC surgery. Future research could also benefit from identifying neuroendocrine tumors. More research focusing on standardization and combining tumor identification and vital-structure imaging would greatly improve FGS’s use during PDAC surgery.

16 April 2014 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
FDFernando D. Dip
Fernando D. Dip
MNMario Nahmod
Mario Nahmod
FAFrancisco Suarez Anzorena
Francisco Suarez Anzorena
AMAlejandro Moreira
Alejandro Moreira
LSLuis Sarotto
Luis Sarotto
SWSteven D. Wexner
Steven D. Wexner

13 December 2023 in Surgery
Verified
Journal Article
Open access
KWKevin P. White
Kevin P. White
DSDiego Sinagra
Diego Sinagra
FDFernando Dip
Fernando Dip
RRRaul J. Rosenthal
Raul J. Rosenthal
EMEdgar A. Mueller
Edgar A. Mueller
ARAlberto Rancati
Alberto Rancati
Axillary sentinel lymph node biopsies are standard of care in patients with breast cancer and no clinically apparent metastases. Traditionally, technetium-99m, blue dye, or both have been used to identify sentinel lymph nodes. However, blue dyes miss up to 40% of sentinel lymph nodes, while technetium-99m use is complex, costly, and exposes patients to radiation. Over the past decade, studies have consistently found the biologically inert fluorescent indocyanine green to be 95% to 100% sensitive in detecting breast cancer sentinel lymph nodes, yet indocyanine green remains infrequently used. We conducted an extensive meta-analysis comparing indocyanine green against blue dye, technetium-99m, and the dual-marker combination of technetium-99m + BD. Unlike prior meta-analyses that only assessed either per-case or per-node sentinel lymph node detection, we analyzed the following 5 metrics: per-case and per-node sentinel lymph node detection and metastasis-positive sentinel lymph node sensitivity, and mean number of sentinel lymph nodes/case. We further examined the consistency and magnitude of between-study superiority and statistically significant within-study superiority of each marker against others. For every metric and analysis approach, indocyanine green was clearly superior to blue dye and at least non-inferior, if not superior, to technetium-99m and technetium-99m + blue dye. Assessing the consistency of superiority by at least 2.0%, indocyanine green was superior to blue dye 73 times versus 1, to technetium-99m 42 times versus 9, and to technetium-99m + blue dye 6 times versus 0. Within-study statistically significant differences favored indocyanine green over blue dye 29 times versus 0 and over technetium-99m 11 times versus 2. For sentinel lymph node detection in patients with breast cancer with no clinically apparent metastases, indocyanine green is clearly and consistently superior to blue dye and either non-inferior or superior to technetium-99m and technetium-99m + blue dye.